Beta blockers GDMT for Hypertension

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.396
Version
20230323
PublisherOptum StewardDate2023-03-23T01:02:49-04:00Purpose

(Clinical Focus: Beta blockers listed as guideline-rected medication therapy (GDMT) in the 2017 ACC AHA Hypertension guideline.),(Data Element Scope: INTENTIONALLY LEFT BLANK),(Inclusion Criteria: RxNorm codes (RxCUIs) corresponding to the drugs listed in Figure 5 of the guideline: carvedilol, metoprolol tartrate, metoprolol succinate, nadolol, bisoprolol, propranolol, and timolol),(Exclusion Criteria: None)

Expansion
<<>>>
CodeDisplaySystem
373654http://www.nlm.nih.gov/research/umls/rxnorm
856470http://www.nlm.nih.gov/research/umls/rxnorm
1370512http://www.nlm.nih.gov/research/umls/rxnorm
572582http://www.nlm.nih.gov/research/umls/rxnorm
866419http://www.nlm.nih.gov/research/umls/rxnorm
200031http://www.nlm.nih.gov/research/umls/rxnorm
1162133http://www.nlm.nih.gov/research/umls/rxnorm
1154706http://www.nlm.nih.gov/research/umls/rxnorm
860518http://www.nlm.nih.gov/research/umls/rxnorm
866472http://www.nlm.nih.gov/research/umls/rxnorm
371103http://www.nlm.nih.gov/research/umls/rxnorm
866411http://www.nlm.nih.gov/research/umls/rxnorm
860524http://www.nlm.nih.gov/research/umls/rxnorm
216221http://www.nlm.nih.gov/research/umls/rxnorm
8787http://www.nlm.nih.gov/research/umls/rxnorm
203191http://www.nlm.nih.gov/research/umls/rxnorm
745976http://www.nlm.nih.gov/research/umls/rxnorm
856481http://www.nlm.nih.gov/research/umls/rxnorm
1999035http://www.nlm.nih.gov/research/umls/rxnorm
856400http://www.nlm.nih.gov/research/umls/rxnorm